Pro Medicus Limited (ASX:PME) Insider Peter Kempen Sells 3,611 Shares of Stock

Pro Medicus Limited (ASX:PME – Get Rating) insider Peter Kempen sold 3,611 shares of the business’s stock in a transaction dated Monday, March 13th. The stock was sold at an average price of A$61.24 ($40.83), for a total transaction of A$221,152.08 ($147,434.72).

Peter Kempen also recently made the following trade(s):

Get Pro Medicus alerts:

• On Wednesday, March 8th, Peter Kempen sold 15,000 shares of Pro Medicus stock. The stock was sold at an average price of A$62.18 ($41.45), for a total transaction of A$932,715.00 ($621,810.00).
• On Friday, March 10th, Peter Kempen sold 10,000 shares of Pro Medicus stock. The stock was sold at an average price of A$61.19 ($40.79), for a total transaction of A$611,920.00 ($407,946.67).

Pro Medicus Price Performance

The company has a debt-to-equity ratio of 1.74, a quick ratio of 4.39 and a current ratio of 5.50.

Pro Medicus Increases Dividend

The company also recently announced a Interim dividend, which will be paid on Thursday, March 23rd. Shareholders of record on Thursday, March 23rd will be paid a dividend of $0.13 per share. The ex-dividend date is Wednesday, March 1st. This is an increase from Pro Medicus’s previous Interim dividend of $0.07. This represents a yield of 0.22%. Pro Medicus’s payout ratio is 54.17%.

About Pro Medicus

(Get Rating)

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform.

Further Reading

• Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
• GitLab Crashes On Guidance; Analysts Defend 
• Healthcare Stocks With at Least 30 Years of Dividend Increases
• Coinbase Pops As SVB Crumbles To Dust
• Airlines Update Guidance, Shares Head For Different Destinations

Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.